UNSPSC 51172139: Milverine

This classification denotes an antispasmotic agent with the molecular formula C20H20N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83B517YUVM, chemically known as 4-((3,3-diphenylpropyl)amino)pyridine but generally known as milverine, which bears US NIH Compound Identifier 71139. European Medicines Agency schedules Milverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08970MIG. The term MILVERINE is an International Non-Proprietary Name.

UNSPSC 51172139 Milverine, a Commodity code, encompasses drug-testing supplies and laboratory reagents used by state and local criminal justice, health, and social-service agencies for offender monitoring, employee screening, and pharmaceutical compliance programs. State and local procurement under this code spans specimen-collection consumables, immunoassay screening materials, confirmation reagents (LC/MS/MS and GC/MS), and alternative-testing methodologies including oral-fluid and hair-testing supplies. Issuing bodies include county corrections and supervision departments, state health and human-services agencies, and cooperative purchasing alliances serving multi-state and multi-jurisdictional government buyers. The work is typically structured as managed services or supply contracts, with vendors providing both materials and staffing or lab certification support, rather than product-only transactions.

Recent activity centers in Texas and the Upper Midwest. Collin County Community Supervision and Corrections Department issued RFP 2026-327 on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services, with an estimated contract value of $600,000 over two years plus three optional one-year renewals; the scope covers staffing two collection sites in Plano and McKinney, immunoassay screening with confirmation testing, and approximately 25,031 annual tests across five-panel and six-panel screens. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling emerging state interest in direct pharmaceutical supply relationships. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, effective July 1, 2026, with Oregon also participating in the cooperative arrangement.